Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00019175 · ClinicalTrials.gov registry record · Phase 1

Vaccine Therapy With or Without Interleukin-2 in Treating Patients With Recurrent Metastatic Melanoma

A Phase 1 study of Melanoma (Skin), sponsored by National Cancer Institute (NCI).

Completed
Registry status
Phase 1
Development phase
1
Study location

NCT00019175 is a Phase 1 study of Melanoma (Skin) that has completed, run by National Cancer Institute (NCI). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00019175, a Phase 1 study of Melanoma (Skin), has completed, sponsored by National Cancer Institute (NCI).

COMPLETED
Registry status
Phase 1
Development phase
1
Study location

Study Summary

RATIONALE: Vaccines made from an antigen combined with a modified virus may make the body build an immune response to kill tumor cells. Interleukin-2 may stimulate a person's white blood cells to kill melanoma cells. Combining vaccine therapy with interleukin-2 may kill more tumor cells. PURPOSE: Phase I trial to compare the effectiveness of vaccine therapy with or without interleukin-2 in treating patients who have recurrent metastatic melanoma that has not responded to previous therapy.

Conditions Studied

Melanoma (Skin)

Interventions

  • BIOLOGICAL aldesleukin
  • BIOLOGICAL gp100 antigen
  • BIOLOGICAL fowlpox virus vaccine vector

Study Locations (1)

Maryland

  • Surgery Branch - Bethesda

Trial Details

FieldValue
Start Date 1996-08
Phase Phase 1

Sponsor

National Cancer Institute (NCI)

3,257 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT00019175

The ClinicalTrials.gov registry entry for NCT00019175 describes a study currently listed as completed, categorized as Phase 1. An enrollment target was not published in the registry record, which is common for early-stage or observational entries. The listed sponsor is National Cancer Institute (NCI), which has 3,257 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Melanoma (Skin) appearing as the primary indexed condition, and to 3 interventions - of which aldesleukin is the first listed.

NCT00019175 reports 1 study location spanning 1 distinct geographic area - top geographies include Maryland.

Frequently Asked Questions

What is clinical trial NCT00019175 about?

NCT00019175 is a clinical study titled "Vaccine Therapy With or Without Interleukin-2 in Treating Patients With Recurrent Metastatic Melanoma". RATIONALE: Vaccines made from an antigen combined with a modified virus may make the body build an immune response to kill tumor cells. Interleukin-2 may stimulate a person's white blood cells to kill melanoma cells. Combining vaccine therapy with interleukin-2 may kill more tumor cells. PURPOSE: P...

What is the current status of trial NCT00019175?

This trial is currently completed. It is a Phase 1 study. The study started on 1996-08.

What conditions does trial NCT00019175 study?

This clinical trial studies the following conditions: Melanoma (Skin).

What interventions are being tested in trial NCT00019175?

The interventions under investigation include: aldesleukin (BIOLOGICAL), gp100 antigen (BIOLOGICAL), fowlpox virus vaccine vector (BIOLOGICAL).

Who is sponsoring clinical trial NCT00019175?

This trial is sponsored by National Cancer Institute (NCI), which has 3,257 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT00019175 being conducted?

This trial has 1 study location across Maryland. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Melanoma (Skin)

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Melanoma (Skin)

All registered trials for this condition

Maryland

All trials with a study site in Maryland

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.